Effects of statin therapy on cerebrovascular and renal outcomes in patients with predialysis advanced chronic kidney disease and dyslipidemia Chang-Min.

Slides:

Advertisements

Similar presentations

Dental implant-retained mandibular overdenture therapy: A clinical study of patients' response Yu-Hwa Pan, Ling-Ming Yu, Tai-Min Lin Journal of Dental.

Advertisements

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Colloquium on Therapy of Right Heart Failure

Individual omega-9 monounsaturated fatty acids and mortality—The Ludwigshafen Risk and Cardiovascular Health Study Graciela E. Delgado, MSc, Bernhard.

Beta blockers in the management of chronic kidney disease

Volume 13, Issue 6, Pages (June 2016)

Clinical outcomes of septic patients with diabetic ketoacidosis between 2004 and 2013 in a tertiary hospital in Taiwan Yu-Chen Cheng, Chung-Hao Huang,

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.

An assessment by the Statin Muscle Safety Task Force: 2014 update

An assessment by the Statin Liver Safety Task Force: 2014 update

Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Mitchell H. Rosner, W. Kline Bolton Kidney International

Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients Jiacong Luo, MD, MS, MPH, Donna E.

Volume 83, Issue 3, Pages (March 2013)

Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with.

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Volume 91, Issue 1, Pages (January 2017)

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Volume 93, Issue 4, Pages (April 2018)

Multidisciplinary Care Program for Advanced Chronic Kidney Disease: Reduces Renal Replacement and Medical Costs Ping Min Chen, MD, Tai Shuan Lai, MD,

MyPlate for Healthy Eating With Chronic Kidney Disease (MyPlate Education for Patients With Chronic Kidney Disease Receiving Hemodialysis and Peritoneal.

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

The US Renal Data System “Pie Chart of Death”

Cardiovascular Disease and CKD: Core Curriculum 2010

Jonathan C. Cohen, PhD Journal of Clinical Lipidology

Hypertensive Disorders in Pregnancy and Subsequent Diabetes Mellitus: A Retrospective Cohort Study I-Kuan Wang, MD, I-Ju Tsai, MS, Pei-Chun Chen, PhD,

CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation

Volume 82, Issue 8, Pages (October 2012)

Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G

Multidisciplinary Care Program for Advanced Chronic Kidney Disease: Reduces Renal Replacement and Medical Costs Ping Min Chen, MD, Tai Shuan Lai, MD,

Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study Vasilios Papademetriou, MD, DSc, Eric.

Volume 87, Issue 6, Pages (June 2015)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States Sudhir K. Unni, PhD, MBA, Ruben G.W.

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Guidelines for the Older Adult With CKD

Higher triglyceride level predicts hyperuricemia: A prospective study of 6-year follow-up Yuan Zhang, Fengjiang Wei, PhD, Chen Chen, MD, Chunyou Cai,

Nutritional Considerations for Dialysis Vegetarian Patients, Part One

Lifetime Incidence of CKD Stages 3-5 in the United States

Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease Johannes F.E. Mann, Qi-Long.

C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go

Optimal high-density lipoprotein cholesterol cutoff for predicting cardiovascular disease: Comparison of the Korean and US National Health and Nutrition.

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations Chao-Hua.

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

On Statin Treatment to Prevent Sepsis in Dialysis Patients

CKD and the Risk of Acute, Community-Acquired Infections Among Older People With Diabetes Mellitus: A Retrospective Cohort Study Using Electronic Health.

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Acute myocardial infarction in patients with end-stage renal disease

Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House

Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials Allan D. Sniderman, MD, James A. Sloand,

Baseline Characteristics of the Subjects*

Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease Neuza Helena Lopes, MD, PhD, Felipe da Silva Paulitsch, MD,

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

Trends and Outcomes Associated With Serum Albumin Concentration Among Incident Dialysis Patients in the United States George A. Kaysen, MD, PhD, Kirsten.

Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia Martine Paquette, MSc, Sophie.

Volume 76, Issue 8, Pages (October 2009)

Volume 80, Issue 6, Pages (September 2011)

Lynda Anne Szczech, Ira L. Lazar Kidney International

Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor? Peter A. Mccullough, Sandeep Soman Kidney.

Volume 72, Issue 4, Pages (August 2007)

Volume 80, Issue 12, Pages (December 2011)

Volume 75, Issue 1, Pages (January 2009)

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Presentation transcript:

Effects of statin therapy on cerebrovascular and renal outcomes in patients with predialysis advanced chronic kidney disease and dyslipidemia Chang-Min Chung, MD, Ming-Shyan Lin, MD, Jen-Te Hsu, MD, Ju-Feng Hsiao, MD, Shih-Tai Chang, MD, Kuo-Li Pan, MD, Chun-Liang Lin, MD, Yu-Sheng Lin, MD Journal of Clinical Lipidology Volume 11, Issue 2, Pages 422-431.e2 (March 2017) DOI: 10.1016/j.jacl.2017.01.001 Copyright © 2016 National Lipid Association Terms and Conditions

Journal of Clinical Lipidology 2017 11, 422-431. e2DOI: (10. 1016/j Journal of Clinical Lipidology 2017 11, 422-431.e2DOI: (10.1016/j.jacl.2017.01.001) Copyright © 2016 National Lipid Association Terms and Conditions

Figure 1 Flowchart of the study design. CKD, chronic kidney disease; ESA, erythropoietin-stimulating agent. Journal of Clinical Lipidology 2017 11, 422-431.e2DOI: (10.1016/j.jacl.2017.01.001) Copyright © 2016 National Lipid Association Terms and Conditions

Figure 2 Kaplan–Meier curves for all-cause mortality and renal outcomes in the statin and nonstatin groups. (A)The cumulative incidence of all-cause mortality. (B) The cumulative incidence of dialysis. The inset shows the same data on an enlarged x-axis. Journal of Clinical Lipidology 2017 11, 422-431.e2DOI: (10.1016/j.jacl.2017.01.001) Copyright © 2016 National Lipid Association Terms and Conditions

Figure 3 The incidence of all-cause mortality grouped according to different baseline data. The baseline characteristics included age, sex, diabetes mellitus, hypertension, congestive heart failure, ischemic heart failure, history of myocardial infarction, and stroke. Journal of Clinical Lipidology 2017 11, 422-431.e2DOI: (10.1016/j.jacl.2017.01.001) Copyright © 2016 National Lipid Association Terms and Conditions